Research into metabolic reprogramming in cancer has become commonplace, 28 yet this area of research has only recently come of age in nephrology. In light of the 29 parallels between cancer and ADPKD, the latter is currently being studied as a 30 metabolic disease. In clear cell renal cell carcinoma (RCC), which is now considered a 31 metabolic disease, we and others have shown derangements in the enzyme 32 arginosuccinate synthase (ASS1) resulting in RCC cells becoming auxotrophic for 33 arginine and leading to a new therapeutic paradigm involving reducing extracellular 34 arginine. Based on our earlier finding that glutamine pathways are reprogrammed in 35 ARPKD, and given the connection between arginine and glutamine synthetic pathways 36 via citrulline, we investigated the possibility of arginine reprogramming in ADPKD. We 37 now show that, in a remarkable parallel to RCC, ASS1 expression is reduced in murine 38 
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Arginine defined media was MEK media prepared with arginine, lysine and glutamine 105 free DMEM/F-12 (Caisson Laboratories Inc), supplemented with 0.5 mM lysine (Sigma-106 Aldrich), 2.5 mM GlutaMAX (ThermoFisher) and various concentrations of L-arginine 107 monohydrochloride (Sigma-Aldrich). The concentration of arginine in the lot of FBS 108 used for all experiments was measured to be 3.38 µM so the actual concentration of 109 arginine in our 0 mM arginine MEK media was 0.07 µM. 110 were stained either with Thiazolyl Blue Tetrazolium Bromide (MTT) as previously 116 described(17) or with methylene blue as previously described(5). qPCR were all performed as previously described(45) with the following modifications: 147 in addition to Rn18S, two new housekeeping genes (Eef2 and Rpl13a) were chosen for 148 normalization of mouse Ass1 mRNA based on multiple instances identifying them as 149 excellent housekeeping genes(6, 7, 21) (Supplemental Table 1 ). Standard curves for 150 qPCR were prepared using 6 or 7 five-fold dilutions of human or mouse normal kidney 151 cDNA. All standard curves had a linear regression coefficient of determination of at 152 least 99%. The mRNA or rRNA levels of each gene in each mouse or human sample 153 were calculated using a relative standard curve of cDNA quantity plotted against Ct. 154
Normalization of gene expression relative to three housekeeping (reference) genes was 155 completed according to the formula: 156 gDNA was extracted from tissue samples and cell lines using the DNAeasy 162
Tissue Kit (Qiagen). The EZ DNA Methylation Kit (Zymo Research Corporation, Irvine, 163 CA) was used on 500 ng purified gDNA to convert unmethylated cytosine residues to 164 uracil while not affecting methylated cytosines. Methylation-specific PCR (MSP) of the 165 hASS1 gene was performed as previously described(27) using primers in Supplemental 166 Ex vivo cystogenesis assays were performed as previously described(2, 16, 26). 213
Briefly, metanephroi were dissected from embryonic CD1 mice at embryonic day 13.5 214 and placed on transparent Transwell cell culture inserts (Corning). DMEM/F12-defined 215 culture medium (supplemented with 2 mml/l L-glutamine, 15 mmol/l N-2-216 hydroxyethylpiperazine-N0-2-ethanesulfonic acid, 5 mg/ml transferrin, 10 mmol/l sodium 217 selenite and 10 mmol/l prostaglandin E1; all from Sigma-Aldrich) was added to the 218 basal chamber, and organ cultures were maintained in a 37 o C humidified CO 2 incubator 219 for up to 5 days. To induce cystogenesis, the culture medium was supplemented with 220 100 µmol/l 8-bromoadenosine 30,50-cyclic monophosphate (8-Br-cAMP; Sigma-Aldrich) 221 and culture media containing either 0.25 mg/ml, 0.12 mg/ml or 0.06 mg/ml arginine was 222 changed daily. Kidneys were imaged every 24 hours for 5 days using a 2x or 4x 223 objective. Quantification of cystic number and area was performed using NIS-Elements 224 AR 4.20 software (Nikon). Four kidneys were analyzed per experimental sample. 225
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RESULTS
227
Since an early indication of arginine reprogramming and auxotrophy in kidney 228 cancer was gleaned from the observation that ASS1 levels were decreased in RCC 229 tumors, we first evaluated protein and mRNA levels of this enzyme in mouse models of 230 ADPKD as well as in tissues from ADPKD affected individuals. The mouse embryonic 231 kidney cell line MEK-wt and its Pkd1-null counterpart MEK-null(54), as well as the Pkd1 232 heterozygous postnatal kidney cell line PH2 and its homozygous Pkd1-null counterpart 233 PN24(41), both showed markedly decreased levels of ASS1 protein and mRNA in the 234
Pkd1-null cells as compared to the wild-type cells (Fig. 1a) . We also quantitated ASS1 235 protein and mRNA levels in the well-established early-stage ADPKD mouse model 236 
ASS1 expression (Figs 2G, H and J). 252
We further examined which cells are expressing ASS1 in mouse kidneys using 253 immunohistochemical stains (Fig. 3 ). Similar to human kidneys, in mice there is 254 substantial murine Ass1 (mAss1) staining in proximal epithelial cells and minimal mAss1 255 staining in distal tubule and glomerular cells from P5 kidneys of wild-type mice as well 256 as mice either heterozygous or homozygous for Pkd1 mutation (Figs. 2 and 3) . In 257 contrast to the human kidney, there was minimal mAss1 expression in the parietal 258 epithelium of the Bowman capsule (Fig. 3) . Whereas in the human the cystic epithelium 259 is generally stained with ASS1, in mice, at P14 and 21 after cysts have developed, the 260 cystic epithelium is variably stained for mAss1, but substantial fibrosis is present in both 261 (Fig. 5b) . 278
species (Figs. 2 and 3). Using immunoblotting to quantify the expression of mAss1 in 262
Pkd1
While the Pkd1 +/-(PH2) cell line did increase ASS1 protein expression after 2 weeks of 279 culturing in 0 mM vs 0.7 mM arginine this increase was not consistent with the ASS1 280 mRNA levels (Fig. 5b) . 281
In RCC and other cancers, ASS1 regulation occurs via epigenetic promotor 282 methylation(15, 22), and for this reason we asked whether the same mechanism occurs 283 in ADPKD to shut down ASS1 expression. Evaluation of human ADPKD and 284
flox/flox :Pkhd1-Cre tissues, with human and mouse RCC as positive controls, 285
showed no methylation of the ASS1 promoter in ADPKD (Fig. 6) . Thus, the loss of 286 expression of this enzyme may be in part due to atrophy of high hASS1/mAss1 287 expressing proximal tubule cells in cystic kidneys (see above and Figs. 2 and 3) . 288
Since all of the ADPKD cell lines and tissues studied expressed decreased levels 289 of ASS1 protein as compared to "normal" cells and tissues, which implies arginine 290 auxotrophy in ADPKD, we asked whether there was an effect of media arginine 291 depletion on proliferation of these cells. When grown in several concentrations of media 292 arginine, there was a differential effect between Pkd1-null and wild-type growth and 293 viability in both cell lines, with the Pkd1-null cells displaying significantly less growth and 294 viability with decreased arginine concentrations compared to the wild-type cells (Fig. 7) . 295
The PN24 cells were significantly more growth inhibited than PH2 cells when grown in 296 0-0.01 mM arginine (Fig. 7a) while the MEK Pkd1-null cells were significantly more 297 growth inhibited than MEK WT cells when grown in 0.001-0.1 mM arginine (Fig. 7b) . 298
The arginine EC50s were higher in the Pkd1-null cell lines compared to their respective 299 wild-type cell line in both MTT and methylene blue assays (Table 1 ). The EC50s also 300 confirm that the embryonic MEK Pkd1-null cells with lower expression of mAss1 (Fig.  301   1a) were more sensitive to arginine deprivation than the adult Pkd1-null cells (PN24). 302
To determine whether arginine depletion decreases cystogenesis, we first utilized 303 an in vitro matrigel-based approach(12). The two Pkd1-null cell lines grew larger cysts 304 than their WT control lines (p<0.05; Fig. 8 ). The PH2 cell line grew very few cysts (data 305 not shown) and the size was mostly unaffected by arginine concentration (Fig. 8) . The 306 growth of PN24, MEK Pkd1-null and MEK-WT cysts was not decreased by culturing in 307 0.1 mM compared to 0.7 mM arginine but in all three lines cysts were significantly 308 smaller in 0.01 mM compared to 0.1 mM and smaller again in 0.001 mM compared to 309 0.01 mM arginine. MEK Pkd1-null cysts were also significantly smaller in 0 mM 310 compared to 0.001mM arginine (Fig. 8) . Thus, arginine-dependent cystogenesis in 311 PKD-model cells parallels changes in growth and viability, all phenomena being more 312 pronounced in these cells than in normal cells. 313
Next, we tested the effects of arginine depletion in an already established(2, 26, 314 42) ex vivo cystogenesis assay using metanephric organ cultures(17). Under basal 315 culture conditions, wild-type kidneys from embryonic day 13.5 mice grow in size and 316 continue ureteric bud branching and tubule formation over a 4-to 5-day period. 317
Treatment of these kidneys with cyclic AMP (cAMP) analogues induces the formation of 318 cysts, which continue to enlarge over several days. Incubation of kidneys in medium 319 containing the normal concentration of arginine for 5 days in the presence of exogenous 320 cAMP resulted in significant cyst formation (Fig. 9) . In contrast, reduction in media 321 arginine concentration (to 50% and 25% of normal, respectively) attenuated 322 cystogenesis in an arginine dose-dependent manner (Fig. 9) . 323
To begin to evaluate a mechanism and rationale for arginine auxotrophy in 324 ADPKD cells, we used a non-targeted metabolomics approach similar to what we have 325 previously accomplished in several ARPKD studies(16, 43). We grew the cells in 326 arginine-deficient media which served to amplify the specific effect of an arginine-327 deficient environment, and we compared the metabolome of all four cell lines grown in 328 arginine-deficient to those grown in arginine-replete media (Supplemental Table 3 ). Of 329 the many cell-type differences occurring in primary metabolite levels after 18 hours of 330 culture with or without arginine, the most consistent changes with arginine depletion 331 were those in amino acid metabolism pathways, with glutamine and proline pathways 332 being the most affected (Supplemental Table 3 ; Fig. 10 ). Strikingly, cellular glutamine 333 was increased with arginine deprivation in all cell lines up to 25.1-fold (p≤0.02; 334 Supplemental Table 3 ), while oxoproline and trans-4-hydroxyproline were increased up 335 to 6.7-fold (p≤0.02). Only acylcarnitine (C2:0) and citric acid were decreased in all cell 336 lines (p≤0.02). Hippuric acid, pyruvate, and beta-alanine were all decreased in 3 of the 4 337 cell lines (p≤0.04; Fig. 10) . Intriguingly, arginine, citrulline, ornithine, alpha-ketoglutarate 338 and lysine were decreased only in the PH2/PN24 cells, while ornithine was actually 339 increased 2-3-fold (p≤0.06) in MEK-WT and Pkd1-null cells with arginine depletion 340 (Supplemental Table 3 ). This may indicate that embryonic kidney cells in the collecting 341 ducts (MEK) are more efficient at (1) conserving arginine, (2) transporting citrulline and 342 the remaining arginine from the arginine deficient media, and/or (3) converting citrulline 343 into arginine and ornithine. 344
To validate the glutamine finding, we used arginine deiminase (ADI) to attenuate 345 arginine in normal media (Fig. 11a) . Pkd1-null cells (with decreased ASS1) grown in this 346 media produced more glutamate than their wild-type counterparts (Fig. 11b) .
Arginine is classified as a semi-essential or conditionally essential amino acid, 354 depending on the developmental stage as well as the health status of the individual. 355
Normal kidney cells make arginine from citrulline, and arginine is converted to ornithine 356 by arginase. Ornithine can subsequently be converted into glutamate, glutamine, alpha-357 ketoglutarate, gamma-aminobutyric acid, or putrescine(23). Preterm infants are unable 358 to synthesize arginine, and adult burn patients have a higher than normal requirement 359 for arginine(51, 52) making the amino acid nutritionally essential for these individuals. 360
The finding that arginine is essential for many malignancies may reflect the "stem-ness" 361 of this disease and its relationship to an earlier developmental stage(3). Given the 362 similarity of PKD to the malignant process(40), it is fascinating that a similar arginine 363 auxotrophic phenomenon (36, 46, 49, 50) appears to be occurring in cystogenesis. 364
We have studied the expression of ASS1 at the cellular level in human ADPKD 365 and a mouse model of ADPKD. In human ADPKD it is likely that atrophy of the proximal 366 tubules, which is concomitant with cystogenesis(31), is responsible for the loss of a 367 significant number of ASS1 expressing cells. In the mouse model we hypothesize that 368 the development of cysts and concomitant fibrosis of the kidney, which is known to 369 result in a reduction in healthy tubular tissue (14) pathway that allows cystic epithelia to proliferate and/or escape normal cell death 383 pathways. Extant data suggest a variety of mechanisms by which arginine depletion 384 may lead to "success" in cancer, such as accumulated aspartate being available for 385 pyrimidine synthesis(37), accumulation of ornithine which can then be applied to 386 polyamine production(33), and even modulation of T-cell activity contributing to 387 differences in the basic metabolism of embryonic collecting duct (MEK) vs. adult 391 (PH2/PN24) proximal tubule kidney cells or (2) the lack of a "true" WT adult kidney cell 392 to use as a comparator for the PN24 cells, given that the PH2 cells are heterozygous for 393 the Pkd1 gene and (3) much lower levels of mAss1 in MEK Pkd1-null vs PN24 Pkd1-394 null cells. However, and most strikingly, we did find significant effects of arginine 395 depletion on various metabolites, five of which were consistently changed in all four cell 396 lines studied and thus they are generalizable to renal tubular cell biology in the 397 presence of arginine deficiency (which is a model for arginine auxotrophy which would 398 be present in PKD cells in the absence of ASS1). Glutamine is one of the cellular 399 metabolites that was increased with arginine deficiency. Since the kidney is very 400 efficient at transporting amino acids(4), it is tempting to speculate that arginine 401 deprivation results in an increased uptake of glutamine to act as a substrate to make 402 citrulline and thus arginine(44). In light of our previous glutamine data in ARPKD(16) 403 and abundant data from us and others in RCC(1, 47, 48), it is likely that decreasing 404 synthesis of arginine through decreased ASS1 expression leads to a reliance on 405 glutamine, which is consistent with possible glutamine addiction in PKD. Such a 406 possibility is currently being evaluated using the glutaminase inhibitor CB839(10, 28) in 407 our laboratories. 408
We further hypothesize that media arginine depletion leads alterations in proline 409 metabolism. For example, ornithine could be converted in the mitochondria to 1-410 pyrroline-5-carboxylate which can be transported to the cytosol and converted to 411 proline(20), which can be further catabolized to 4-hydroxyproline, which we observed to 412 be increased with arginine depletion. The increase in 5-oxoproline, which can be 413 
